IL6 and breast carcinoma: Furthermore, blocking IL-6 signalling with siRNA and neutralising antibody in co-cultured breast cancer cells and adipocyte media, resulted in increased E-cadherin, and attenuation of EMT-related genes such as TWIST and N-cadherin (Fig. 7e,f).